Predictors of clinical worsening during a discontinuation trial of serotonin reuptake inhibitors for obsessive compulsive disorder
Authors:
- 4 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 101, 102805
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderatorsJournal of Psychiatric Research, 2013
- Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive–compulsive disorderPsychological Medicine, 2010
- A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and HumanScience, 2010
- Genetic Gating of Human Fear Learning and ExtinctionPsychological Science, 2009
- Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-AnalysisBiological Psychiatry, 2008
- Female hormones affect symptom severity in obsessive–compulsive disorderInternational Clinical Psychopharmacology, 2006
- A short form of the metacognitions questionnaire: properties of the MCQ-30Behaviour Research and Therapy, 2004
- Insight in obsessive compulsive disorder and body dysmorphic disorderComprehensive Psychiatry, 2004
- Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive DisorderAmerican Journal of Psychiatry, 2002
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989